Global Leading Market Research Publisher QYResearch announces the release of its latest report “Disposable Liquid Dispensing System – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Disposable Liquid Dispensing System market, including market size, share, demand, industry development status, and forecasts for the next few years.
For biopharmaceutical manufacturers (mAbs, vaccines, cell therapies), transferring media, buffers, and process fluids between vessels traditionally required stainless steel transfer panels, hoses, and cleaning validation. The disposable liquid dispensing system addresses this through single-use aseptic fluid delivery: modular devices with single-use bags, tubing, pumps, and sensors, using PLC-based automation to control volume and flow rate with ±1-2% accuracy, eliminating cleaning burdens and reducing setup time. According to QYResearch’s updated model, the global market for Disposable Liquid Dispensing System was estimated to be worth US$ 584 million in 2025 and is projected to reach US$ 771 million, growing at a CAGR of 4.1% from 2026 to 2032. In 2024, global Disposable Liquid Dispensing System sales reached approximately 8,300 units, with an average global market price of around US$ 67,000 per unit. Disposable Liquid Dispensing System is a modular aseptic liquid-handling device for precise delivery of media, buffers, or other process fluids in biopharmaceutical production. Comprising single-use bags, tubing, pumps, and sensors, it employs PLC-based automation to control volume and flow rate with ±1% accuracy. Its primary value lies in eliminating cleaning burdens of stainless-steel systems and reducing setup time via pre-sterilized components. The system supports multi-channel dispensing into varied recipients (e.g., bioreactors or storage bags), scaling from lab to commercial production. For highly active or viscous liquids, specialized tubing and connectors prevent residue or clogging. As the industry prioritizes cost efficiency and flexibility, this system has become pivotal for standardized and continuous bioprocessing.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6095881/disposable-liquid-dispensing-system
1. Technical Architecture: Capacity and Applications
Disposable liquid dispensing systems are segmented by capacity range, determining scale of bioprocessing operations:
| Capacity Range | Typical Volume per Batch | Applications | Pump Type | Accuracy | Price (USD) | Market Share (Units) |
|---|---|---|---|---|---|---|
| 50L-1000L | 100-800L | Media transfer to bioreactors, buffer preparation, small-scale dispensing | Peristaltic or diaphragm | ±1-2% | $40-80k | 60% |
| 1000L-2000L | 500-1,500L | Large-scale media/buffer transfer, harvest collection, commercial production | Peristaltic (high-flow) | ±1-2% | $80-120k | 35% |
| Others (2000L+) | 1,500-5,000L | Bulk dispensing, tank filling, continuous bioprocessing | Progressive cavity | ±1-3% | $120-200k | 5% |
Key technical challenge – accurate dispensing of viscous or cell-containing fluids: Shear-sensitive cells (CHO, HEK293) and viscous solutions (high-concentration mAbs) require gentle pumping. Over the past six months, several advancements have emerged:
- Cobetter (February 2026) introduced a peristaltic pump-based dispensing system with low-shear tubing (silicone, 6.4mm ID), maintaining cell viability >95% after pumping (vs. 85% for standard pumps), critical for cell therapy manufacturing.
- LePure Biotech (March 2026) commercialized a diaphragm pump dispensing system with ±0.5% accuracy for high-viscosity solutions (up to 500 cP, mAb formulations), eliminating pulsation and residue in tubing.
- Tofflon (January 2026) launched an automated dispensing system with integrated weight verification (load cells) and barcode scanning, achieving 21 CFR Part 11 compliance for electronic records and signatures (FDA-regulated manufacturing).
Industry insight – unit economics: 8,300 units in 2024, ASP $67,000. Cost breakdown: single-use bags (20-30%), pump/controller (25-35%), tubing/manifold (10-15%), sensors (5-10%), cart/stand (5-10%), assembly/testing (10-15%). Larger capacity systems (1000-2000L) have higher ASP ($80-120k).
2. Market Segmentation: Capacity and Application
The Disposable Liquid Dispensing System market is segmented as below:
Key Players: Cobetter (China), Tofflon (China), LePure Biotech (China), Applitech (China), Wuhan CEKG Tech (China), Shanghai Baigaole Biotechnology (China), Truking Technology (China), BioLink (China), Morimatsu (China), AUSTAR (China), JYSS BIO (China), Duoning Biotech (China), Lisure Science (China), Topgun Biotech (China)
Segment by Capacity:
- 50L-1000L – Largest segment (60% of 2025 units). R&D, pilot-scale, small-batch manufacturing.
- 1000L-2000L – 35% of units (fastest-growing, 5% CAGR). Commercial manufacturing, large-scale buffer prep.
- Others (2000L+) – 5% of units. Continuous bioprocessing, bulk dispensing.
Segment by Application:
- Culture Medium – Largest segment (40% of revenue). Transferring cell culture media to bioreactors (CHO, HEK293, Vero cells).
- Buffer Solution – 30% of revenue. Chromatography buffers (equilibration, wash, elution), diafiltration buffers, formulation buffers.
- Dilution Solution – 15% of revenue. Diluting concentrated drug substances, intermediate dilutions.
- Vaccine Adjuvant – 10% of revenue. Dispensing aluminum hydroxide, MF59, AS01 adjuvants (requires accurate, low-shear transfer).
- Others – Harvest pools, viral vectors, mRNA formulations (5% of revenue).
Typical user case – commercial mAb buffer preparation: A 10,000L mAb manufacturing facility requires 20,000L of chromatography buffer weekly. Disposable dispensing system (LePure, 1500L capacity, $100k) transfers buffer from prep bags to 2,000L bioreactors. Accuracy: ±1% (20L error on 2,000L). Benefits: eliminates stainless steel transfer lines (no CIP/SIP), reduces setup time from 2 hours to 15 minutes, and prevents cross-contamination (single-use). Annual labor savings: $50k. Payback: 2 years.
Exclusive observation – “continuous bioprocessing” driver: Continuous biomanufacturing (perfusion, continuous chromatography) requires precise, low-shear liquid dispensing for sustained operation (weeks to months). Disposable dispensing systems with integrated sensors (pH, DO, pressure) and automated control are essential. Continuous bioprocessing market growing at 15% CAGR, driving demand for advanced dispensing systems.
3. Regional Dynamics and Biopharma Manufacturing
| Region | Market Share (2025) | Key Drivers |
|---|---|---|
| Asia-Pacific | 50% | Largest biopharma manufacturing (China, India), domestic equipment suppliers (Cobetter, Tofflon, LePure, Truking, Morimatsu), cost leadership |
| North America | 25% | mAb and cell therapy manufacturing (US), high automation adoption |
| Europe | 20% | Vaccine production (EU), mAbs (Switzerland, Germany, UK) |
| RoW | 5% | Emerging biopharma (Brazil, Singapore) |
Exclusive observation – “modular, skid-mounted” systems: Pre-assembled dispensing skids (pumps, controls, bag holders) reduce on-site installation time from weeks to days. Skid-mounted systems have ASP $150-300k (2-3x basic systems). Modular design allows expansion (add dispensing heads) as production scales. Skid-mounted segment growing at 6% CAGR.
4. Competitive Landscape and Outlook
| Tier | Supplier | Key Strengths | Focus |
|---|---|---|---|
| 1 | Global leaders | Cytiva (not listed), Sartorius (not listed) (indirectly via partnerships) | Full single-use bioprocessing portfolio, global distribution (but limited direct presence in China domestic market) |
| 1 | Chinese domestic leaders | Cobetter, Tofflon, LePure, Truking, Morimatsu, BioLink, Duoning, AUSTAR, JYSS BIO, Applitech, Wuhan CEKG, Shanghai Baigaole, Lisure Science, Topgun Biotech | Cost leadership (30-50% below global), domestic market dominance, fast customization, expanding export |
Technology roadmap (2027-2030):
- Single-use sensor integration – Integrated single-use pH, DO, pressure, and flow sensors (optical, ultrasonic) for real-time process monitoring (no sensor insertion ports).
- Automated bag loading/unloading – Robotic bag handling for high-throughput dispensing (reducing operator exposure to potent compounds).
- RFID-tracked single-use components – Bags, tubing, filters with RFID tags for automated inventory management and lot traceability (21 CFR Part 11 compliance).
With 4.1% CAGR and 8,300 units sold in 2024 (projected 11,000+ by 2030), the disposable liquid dispensing system market benefits from biopharma growth (mAbs, vaccines, cell therapies), single-use adoption, and cleaning validation elimination. Risks include supply chain disruptions (bag films, tubing resins, pump components), competition from reusable stainless steel systems (lower consumable cost), and price pressure from domestic Chinese manufacturers (30-50% lower ASP).
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
